Inhibitory effect of spinal mGlu(5) receptor antisense oligonucleotide on the up-regulated expression of spinal G protein associated with chronic morphine treatment
- PMID: 24296320
- DOI: 10.1016/j.ejphar.2013.11.024
Inhibitory effect of spinal mGlu(5) receptor antisense oligonucleotide on the up-regulated expression of spinal G protein associated with chronic morphine treatment
Abstract
Knockdown of spinal metabotropic glutamate 5 (mGlu5) receptor was shown to inhibit the development of intrathecal morphine antinociceptive tolerance. The present work was designed to evaluate the expression of spinal G-protein during morphine tolerance and knockdown of spinal mGlu5 receptor with antisense oligonucleotide (ODN). Rats were treated with saline, morphine, mGlu5 receptor antisense or mismatch ODN intrathecally. Behavioral tests were employed to test the thermal and mechanical pain thresholds. Five days later, rats were scarified and spinal expression of spinal Gαi, Gαo, Gαq and Gβ were detected. Consistent with the previous results, knockdown of spinal mGlu5 receptor could inhibit spinal morphine antinociceptive tolerance in behavioral tests (P<0.05). The mGlu5 receptor antisense ODN produced a significant reduction in mGlu5 receptor protein of about 56.6% compared with the control group (P<0.05). Expression of spinal Gαi, Gαo, Gαq and Gβ were up-regulated while morphine tolerance developed (P<0.05). Antisense ODN of spinal mGlu5 receptor, but not mismatched ODN, reduced the spinal dorsal horn levels of Gαi, Gαo, Gαs, Gαq and Gβ (P<0.05). We conclude that expression of spinal G (αi, αo, αs, αq and β) protein may be up-regulated after chronic morphine treatment which could be attenuated by knockdown of spinal mGlu5 receptor with antisense ODN.
Keywords: G protein; Intrathecal administration; Metabotropic glutamate receptor 5(mGlu(5) receptor); Morphine; Tolerance.
© 2013 Elsevier B.V. All rights reserved.
Similar articles
-
Antisense oligonucleotide knockdown of mGlu₅ receptor attenuates the antinociceptive tolerance and up-regulated expression of spinal protein kinase C associated with chronic morphine treatment.Eur J Pharmacol. 2012 May 15;683(1-3):78-85. doi: 10.1016/j.ejphar.2012.02.046. Epub 2012 Mar 12. Eur J Pharmacol. 2012. PMID: 22429573
-
Attenuation of morphine tolerance after antisense oligonucleotide knock-down of spinal mGluR1.Br J Pharmacol. 2002 Jul;136(6):865-72. doi: 10.1038/sj.bjp.0704792. Br J Pharmacol. 2002. PMID: 12110611 Free PMC article.
-
Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.Synapse. 2003 Feb;47(2):109-16. doi: 10.1002/syn.10149. Synapse. 2003. PMID: 12454948
-
[Involvement of intrathecal activation of MrgC receptor in pathological pain and morphine tolerance].Sheng Li Xue Bao. 2019 Oct 25;71(5):741-748. Sheng Li Xue Bao. 2019. PMID: 31646328 Review. Chinese.
-
Peroxynitrite and opiate antinociceptive tolerance: a painful reality.Arch Biochem Biophys. 2009 Apr 15;484(2):238-44. doi: 10.1016/j.abb.2008.11.005. Epub 2008 Nov 11. Arch Biochem Biophys. 2009. PMID: 19017525 Free PMC article. Review. No abstract available.
Cited by
-
Current and Future Issues in the Development of Spinal Agents for the Management of Pain.Curr Neuropharmacol. 2017;15(2):232-259. doi: 10.2174/1570159x14666160307145542. Curr Neuropharmacol. 2017. PMID: 26861470 Free PMC article. Review.
-
Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance.Pharmaceuticals (Basel). 2023 Nov 3;16(11):1558. doi: 10.3390/ph16111558. Pharmaceuticals (Basel). 2023. PMID: 38004424 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
